missing translation for 'onlineSavingsMsg'
Learn More
Learn More
HLA DRB1 Antibody (HLA-DRB/7058R), Novus Biologicals™
Rabbit Monoclonal Antibody
Marca: Novus Biologicals NBP3-20459-100ug
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
HLA DRB1 Monoclonal antibody specifically detects HLA DRB1 in Human samples. It is validated for Immunohistochemistry (Paraffin)
Specifica
| HLA DRB1 | |
| Monoclonal | |
| 0.2 mg/ml | |
| Immunohistochemistry-Paraffin 1-2 μg/mL | |
| Clone P2-beta-3, DR1, DR-1, DR12, DR-12, DR13, DR-13, DR14, DR-14, DR16, DR-16, DR4, DR-4, DR5, DR-5, DR7, DR-7, DR8, DR-8, DR9, DR-9, DRB1, DRw10, DRw11, DRw8, DW2.2/DR2.2, FLJ75017, FLJ76359, HLA class II antigen beta chain, HLA class II histocompatibility antigen, DR-1 beta chain, HLA-DR1B, HLA-DRB, HLA-DRB1*, HLA-DRB2, HLA-DR-beta 1, human leucocyte antigen DRB1, leucocyte antigen DR beta 1 chain, leucocyte antigen DRB1, lymphocyte antigen DRB1, major histocompatibility complex, class II, DR beta 1, MHC class II antigen DRB1*1, MHC class II antigen DRB1*10, MHC class II antigen DRB1*11, MHC class II antigen DRB1*12, MHC class II antigen DRB1*13, MHC class II antigen DRB1*14, MHC class II antigen DRB1*15, MHC class II antigen DRB1*16, MHC class II antigen DRB1*3, MHC class II antigen DRB1*4, MHC class II antigen DRB1*7, MHC class II antigen DRB1*8, MHC class II antigen DRB1*9, MHC class II antigen HLA-DR13, MHC class II HLA-DR beta 1 chain, MHC class II HLA-DR-beta cell surface gly | |
| Recombinant full-length human HLA DRB1 protein | |
| 100 μg | |
| Adaptive Immunity, Asthma, Cell Biology, Diabetes Research, Immunology | |
| 3123 | |
| Store at 4&drg;C. Do not freeze. | |
| IgG κ |
| Immunohistochemistry (Paraffin) | |
| HLA-DRB/7058R | |
| Unconjugated | |
| 10mM PBS with 0.05% BSA | |
| Rabbit | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| Human | |
| Purified |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto